Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658

Clinical trial NCT01529944 · COMPLETED

Trial details

NCT number: NCT01529944
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Genetic Disorder Noonan Syndrome

Start date: 2008-09-01
Primary completion: 2008-10-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.